Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
7(58%)
Results Posted
50%(2 trials)

Phase Distribution

Ph phase_4
3
25%
Ph phase_1
1
8%

Phase Distribution

1

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 4Post-market surveillance
3(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

7

trials recruiting

Total Trials

12

all time

Status Distribution
Active(7)
Completed(4)
Other(1)

Detailed Status

Recruiting7
Completed4
unknown1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
7
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (25.0%)
Phase 43 (75.0%)

Trials by Status

completed433%
unknown18%
recruiting758%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
PROCEDURE
Total Trials
12